{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T13:48:12Z","timestamp":1781531292258,"version":"3.54.5"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,2,13]],"date-time":"2015-02-13T00:00:00Z","timestamp":1423785600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13014-015-0347-2","type":"journal-article","created":{"date-parts":[[2015,2,12]],"date-time":"2015-02-12T09:01:57Z","timestamp":1423731717000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Infections after fiducial marker implantation for prostate radiotherapy: are we underestimating the risks?"],"prefix":"10.1186","volume":"10","author":[{"given":"Jasmin","family":"Loh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swetha","family":"Sridharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Greer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Wratten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Capp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Gallagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarad","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,13]]},"reference":[{"key":"347_CR1","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1259\/bjr\/68127917","volume":"85","author":"S Gill","year":"2012","unstructured":"Gill S, Li J, Thomas J, Bressel M, Thursky K, Styles C, et al. Patient-reported complications from fiducial marker implantation for prostate image-guided radiotherapy. Br J Radiol. 2012;85:1011\u20137.","journal-title":"Br J Radiol"},{"key":"347_CR2","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.ijrobp.2007.04.009","volume":"69","author":"JF Langenhuijsen","year":"2007","unstructured":"Langenhuijsen JF, van Lin EN, Kiemeney LA, van der Vight LP, McColl GM, Visser AG, et al. Ultrasound-guided transrectal implantation of gold markers for prostate localization during external beam radiotherapy: complication rate and risk factors. Int J Radiat Oncol Biol Phys. 2007;69:671\u20136.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"347_CR3","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1259\/bjr\/14201041","volume":"82","author":"S Igdem","year":"2009","unstructured":"Igdem S, Akpinar H, Alco G, Agacayak F, Turkan S, Okkan S. Implantation of fiducial markers for image guidance in prostate radiotherapy: patient-reported toxicity. Br J Radiol. 2009;82:941\u20135.","journal-title":"Br J Radiol"},{"key":"347_CR4","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.radonc.2010.02.027","volume":"96","author":"MR Moman","year":"2010","unstructured":"Moman MR, van der Heide UA, Kotte AN, van Moorselaar RJ, Bol GH, Franken SP, et al. Long-term experience with transrectal and transperineal implantations of fiducial gold markers in the prostate for position verification in external beam radiotherapy; feasibility, toxicity and quality of life. Radiother Oncol. 2010;96:38\u201342.","journal-title":"Radiother Oncol"},{"key":"347_CR5","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.eururo.2012.06.003","volume":"63","author":"FM Wagenlehner","year":"2013","unstructured":"Wagenlehner FM, van Oostrum E, Tenke P, Tandogdu Z, Cek M, Grabe M, et al. Infective complications after prostate biopsy: outcome of the Global Prevalence Study of Infections in Urology (GPIU) 2010 and 2011, a prospective multinational multicentre prostate biopsy study. Eur Urol. 2013;63:521\u20137.","journal-title":"Eur Urol"},{"key":"347_CR6","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.eururo.2011.12.058","volume":"61","author":"S Loeb","year":"2012","unstructured":"Loeb S, van den Heuvel S, Zhu X, Bangma CH, Schroder FH, Roobol MJ. Infectious complications and hospital admissions after prostate biopsy in a European randomized trial. Eur Urol. 2012;61:1110\u20134.","journal-title":"Eur Urol"},{"key":"347_CR7","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/nrurol.2013.322","volume":"11","author":"FM Wagenlehner","year":"2014","unstructured":"Wagenlehner FM, Pilatz A, Waliszewski P, Weidner W, Johansen TE. Reducing infection rates after prostate biopsy. Nat Rev Urol. 2014;11:80\u20136.","journal-title":"Nat Rev Urol"},{"key":"347_CR8","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s10156-007-0570-3","volume":"14","author":"K Shigehara","year":"2008","unstructured":"Shigehara K, Miyagi T, Nakashima T, Shimamura M. Acute bacterial prostatitis after transrectal prostate needle biopsy: clinical analysis. J Infect Chemother. 2008;14:40\u20133.","journal-title":"J Infect Chemother"},{"key":"347_CR9","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.urology.2011.04.064","volume":"78","author":"AA Mosharafa","year":"2011","unstructured":"Mosharafa AA, Torky MH, El Said WM, Meshref A. Rising incidence of acute prostatitis following prostate biopsy: fluoroquinolone resistance and exposure is a significant risk factor. Urology. 2011;78:511\u20134.","journal-title":"Urology"},{"key":"347_CR10","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.urology.2008.01.065","volume":"72","author":"C Kamdar","year":"2008","unstructured":"Kamdar C, Mooppan UM, Gulmi FA, Kim H. Multi-drug-resistant bacteremia after transrectal ultrasound guided prostate biopsies in hospital employees and their relatives. Urology. 2008;72:34\u20136.","journal-title":"Urology"},{"key":"347_CR11","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1093\/cid\/cis194","volume":"54","author":"DA Williamson","year":"2012","unstructured":"Williamson DA, Roberts SA, Paterson DL, Sidjabat H, Silvey A, Masters J, et al. Escherichia coli bloodstream infection after transrectal ultrasound-guided prostate biopsy: implications of fluoroquinolone-resistant sequence type 131 as a major causative pathogen. Clin Infect Dis. 2012;54:1406\u201312.","journal-title":"Clin Infect Dis"},{"key":"347_CR12","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/j.1469-0691.2011.03638.x","volume":"18","author":"D Steensels","year":"2012","unstructured":"Steensels D, Slabbaert K, De Wever L, Vermeersch P, Van Poppel H, Verhaegen J. Fluoroquinolone-resistant E. coli in intestinal flora of patients undergoing transrectal ultrasound-guided prostate biopsy\u2013should we reassess our practices for antibiotic prophylaxis? Clin Microbiol Infect. 2012;18:575\u201381.","journal-title":"Clin Microbiol Infect"},{"key":"347_CR13","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/S0022-5347(05)66082-X","volume":"166","author":"JM Carey","year":"2001","unstructured":"Carey JM, Korman HJ. Transrectal ultrasound guided biopsy of the prostate. Do enemas decrease clinically significant complications? J Urol. 2001;166:82\u20135.","journal-title":"J Urol"},{"key":"347_CR14","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1086\/502312","volume":"25","author":"ZK Otrock","year":"2004","unstructured":"Otrock ZK, Oghlakian GO, Salamoun MM, Haddad M, Bizri AR. Incidence of urinary tract infection following transrectal ultrasound guided prostate biopsy at a tertiary-care medical center in Lebanon. Infect Control Hosp Epidemiol. 2004;25:873\u20137.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"347_CR15","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.juro.2011.11.115","volume":"187","author":"AK Taylor","year":"2012","unstructured":"Taylor AK, Zembower TR, Nadler RB, Scheetz MH, Cashy JP, Bowen D, et al. Targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound guided prostate biopsy is associated with reduced incidence of postoperative infectious complications and cost of care. J Urol. 2012;187:1275\u20139.","journal-title":"J Urol"},{"key":"347_CR16","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/bju.12536","volume":"114","author":"JP Grummet","year":"2014","unstructured":"Grummet JP, Weerakoon M, Huang S, Lawrentschuk N, Frydenberg M, Moon DA, et al. Sepsis and \u2018superbugs\u2019: should we favour the transperineal over the transrectal approach for prostate biopsy? BJU Int. 2014;114:\u2009384\u20138.","journal-title":"BJU Int"},{"key":"347_CR17","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.juro.2013.08.088","volume":"191","author":"B Ehdaie","year":"2014","unstructured":"Ehdaie B, Vertosick E, Spaliviero M, Giallo-Uvino A, Taur Y, O\u2019Sullivan M, et al. The impact of repeat biopsies on infectious complications in men with prostate cancer on active surveillance. J Urol. 2014;191:660\u20134.","journal-title":"J Urol"},{"key":"347_CR18","unstructured":"Seil E WS, Jack B. Implantation of fiducial markers into the prostate gland or prostatic surgical bed for external beam radiotherapy. MSAC Application 1147, Assessment Report. Commonwealth of Australia, Canberra, ACT; 2013."},{"key":"347_CR19","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.ijrobp.2012.07.2376","volume":"85","author":"J Singh","year":"2013","unstructured":"Singh J, Greer PB, White MA, Parker J, Patterson J, Tang CI, et al. Treatment-related morbidity in prostate cancer: a comparison of 3-dimensional conformal radiation therapy with and without image guidance using implanted fiducial markers. Int J Radiat Oncol Biol Phys. 2013;85:1018\u201323.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"347_CR20","doi-asserted-by":"publisher","first-page":"071707","DOI":"10.1118\/1.4808359","volume":"40","author":"S van der Meer","year":"2013","unstructured":"van der Meer S, Bloemen-van Gurp E, Hermans J, Voncken R, Heuvelmans D, Gubbels C, et al. Critical assessment of intramodality 3D ultrasound imaging for prostate IGRT compared to fiducial markers. Med Phys. 2013;40:071707.","journal-title":"Med Phys"},{"key":"347_CR21","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.ijrobp.2006.10.039","volume":"67","author":"DJ Moseley","year":"2007","unstructured":"Moseley DJ, White EA, Wiltshire KL, Rosewall T, Sharpe MB, Siewerdsen JH, et al. Comparison of localization performance with implanted fiducial markers and cone-beam computed tomography for on-line image-guided radiotherapy of the prostate. Int J Radiat Oncol Biol Phys. 2007;67:942\u201353.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"347_CR22","doi-asserted-by":"crossref","unstructured":"Deegan T, Owen R, Holt T, Fielding A, Biggs J, Parfitt M, et al.. Assessment of cone beam CT registration for prostate radiation therapy: Fiducial marker and soft tissue methods. J Med Imaging Radiat Oncol. Published on-line 22 June 2014. doi:10.1111\/1754-9485.12197.","DOI":"10.1111\/1754-9485.12197"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-015-0347-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13014-015-0347-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-015-0347-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-015-0347-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T05:06:37Z","timestamp":1717736797000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-015-0347-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,13]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["347"],"URL":"https:\/\/doi.org\/10.1186\/s13014-015-0347-2","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,13]]},"assertion":[{"value":"28 August 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"38"}}